Fmr Union Min Suresh Prabhu urges Sadananda Gowda to regulate prices, supply of Mucormycosis medicine
PTI, May 11, 2021, 2:25 PM IST
New Delhi: Former Union Minister Suresh Prabhu on Tuesday urged Chemicals and Fertilisers Minister Sadananda Gowda to regulate the prices and supply of medicine used in the treatment of Mucormycosis, a fungal infection, to ensure that no artificial shortage is created.
In a letter to Gowda, he said that it has been noticed that pharmaceutical companies have raised the prices of Amphotercin, a drug used in the management of this infection and shortage of this medicine has also been reported.
“I would request your urgent intervention in this matter to regulate the prices and supply of the medicine for this deadly Mucormycosis infection to ensure that no artificial shortage is created,” Prabhu said.
He added that there has been an increase in the cases of this disease.
Niti Aayog Member (Health) V K Paul on Friday said Mucormycosis, a fungal infection, is being found in COVID-19 patients and largely in cases of those who are diabetic.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Report on Sambhal mosque survey likely to be submitted to local court; security tight in district
Three women stranded in dense forest rescued
Railway minister dismisses reports of delay in Vande Bharat sleeper trains over design
Mahayuti leaders finalize power sharing pact with Amit Shah; CM’s name awaited
Achieved significant success against terrorism, left-wing extremism, insurgency, narcotics: Amit Shah
MUST WATCH
Latest Additions
KL Rahul should continue to open with Jaiswal, Rohit can come in at 3: Pujara
Mangaluru: Passengers oppose proposed changes to Murudeshwar Express train schedule
Sensex, Nifty bounce back after sharp correction in previous trade
Kundapura: Keradi Kambala, poupularised by movie Kantara, gets underway
Kasaragod: Pension Fraud — 1,458 govt employees found misusing welfare pension
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.